Hereditary transthyretin amyloidosis (ATTRv) is a severe, adult-onset autosomal dominant
inherited systemic disease predominantly affecting the peripheral and autonomic nervous …

Hypertrophic cardiomyopathy is a myocardial disease defined by an increased left
ventricular wall thickness not solely explained by abnormal loading conditions. It is often …

Amyloidosis is a group of disorders that can affect almost any organ due to the misfolding of
proteins with their subsequent deposition in various tissues, leading to various disease …

Diflunisal is a well-known drug for the treatment of rheumatoid arthritis, osteoarthritis,
primary dysmenorrhea, and colon cancer. This molecule belongs to the group of …

Cardiac amyloidosis is a rare, debilitating, and usually fatal disease increasingly recognized
in clinical practice despite patients presenting with non-specific symptoms of …

Hereditary transthyretin (ATTRv) amyloidosis with polyneuropathy, also known as familial
amyloid polyneuropathy (FAP), represents a progressive, heterogeneous, severe, and …

A substantial increase in the interest in transthyretin cardiac amyloidosis (ATTR-CA) is a
result of the constantly growing number of patients, the use of clear diagnostic protocols and …

Amyloidosis is a systemic disease initiated by deposition of misfolded proteins in the
extracellular space, due to which multiple organs may be affected concomitantly. Cardiac …

Aims Whether sodium‐glucose co‐transporter 2 inhibitors are effective for heart failure
caused by ATTR‐CA (transthyretin cardiac amyloidosis) remains uncertain. The aim of this …

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is frequently misdiagnosed or
diagnosed late in the disease course. ATTRwt-CM can be diagnosed invasively through …